Terms: = Lung cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Staging
119 results:
1.
Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
[TBL] [Abstract] [Full Text] [Related]
2. PET-CT SUV
Faria N; Lacerda C; Lopes J; Viana C; Sucena M
Clin Lung Cancer; 2023 Dec; 24(8):753-760. PubMed ID: 37599163
[TBL] [Abstract] [Full Text] [Related]
3.
Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
[TBL] [Abstract] [Full Text] [Related]
4. Clinical utility of [
Zhang L; E H; Huang J; Wu J; Li Q; Hou L; Li C; Dai C; Deng J; Yang M; Ma M; Ren Y; Luo Q; Zhao D; Chen C
Eur Radiol; 2023 Dec; 33(12):8564-8572. PubMed ID: 37464112
[TBL] [Abstract] [Full Text] [Related]
5. 68 Ga-FAPI-04 PET/CT in Selected Breast cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.
Alçın G; Arslan E; Aksoy T; Cin M; Erol Fenercioğlu Ö; Beyhan E; Ergül N; Çermik TF
Clin Nucl Med; 2023 Sep; 48(9):e420-e430. PubMed ID: 37351868
[TBL] [Abstract] [Full Text] [Related]
6. Initial Evaluation of [
Watabe T; Naka S; Tatsumi M; Kamiya T; Kimura T; Shintani Y; Abe K; Miyake T; Shimazu K; Kobayashi S; Kurokawa Y; Eguchi H; Doki Y; Inohara H; Kato H; Mori Y; Cardinale J; Giesel FL
J Nucl Med; 2023 Aug; 64(8):1225-1231. PubMed ID: 37268427
[TBL] [Abstract] [Full Text] [Related]
7. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell lung cancer Patients.
Ohno Y; Yui M; Yamamoto K; Takenaka D; Koyama H; Nagata H; Ueda T; Ikeda H; Ozawa Y; Toyama H; Yoshikawa T
J Magn Reson Imaging; 2023 Jul; 58(1):174-186. PubMed ID: 36971493
[TBL] [Abstract] [Full Text] [Related]
8. Primary tumor SUV
Tas F; Ozturk A; Erturk K
Wien Klin Wochenschr; 2023 Sep; 135(17-18):478-487. PubMed ID: 36882606
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
[TBL] [Abstract] [Full Text] [Related]
10. Computed DWI MRI Results in Superior Capability for N-Stage Assessment of Non-Small Cell lung cancer Than That of Actual DWI, STIR Imaging, and FDG-PET/CT.
Ohno Y; Yui M; Takenaka D; Yoshikawa T; Koyama H; Kassai Y; Yamamoto K; Oshima Y; Hamabuchi N; Hanamatsu S; Obama Y; Ueda T; Ikeda H; Hattori H; Murayama K; Toyama H
J Magn Reson Imaging; 2023 Jan; 57(1):259-272. PubMed ID: 35753082
[TBL] [Abstract] [Full Text] [Related]
11. The Value of the Standardized Uptake Value (SUV) and Metabolic Tumor Volume (MTV) in lung cancer.
Hicks RJ
Semin Nucl Med; 2022 Nov; 52(6):734-744. PubMed ID: 35624032
[TBL] [Abstract] [Full Text] [Related]
12. Impact of Bayesian penalized likelihood reconstruction on quantitative and qualitative aspects for pulmonary nodule detection in digital 2-[
Lohaus N; Enderlin F; Skawran S; Maurer A; Abukwaik AMA; Franzen D; Huellner MW; Messerli M
Sci Rep; 2022 May; 12(1):8308. PubMed ID: 35585129
[TBL] [Abstract] [Full Text] [Related]
13. Higher accuracy of [
Zhou X; Wang S; Xu X; Meng X; Zhang H; Zhang A; Song Y; Zhu H; Yang Z; Li N
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2983-2993. PubMed ID: 35543731
[TBL] [Abstract] [Full Text] [Related]
14. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
15. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
16. Tumor angiogenesis at baseline identified by
Wei Y; Qin X; Liu X; Zheng J; Luan X; Zhou Y; Yu J; Yuan S
J Transl Med; 2022 Feb; 20(1):63. PubMed ID: 35109866
[TBL] [Abstract] [Full Text] [Related]
17. New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB-III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes.
Kameyama K; Imai K; Ishiyama K; Takashima S; Kuriyama S; Atari M; Ishii Y; Kobayashi A; Takahashi S; Kobayashi M; Harata Y; Sato Y; Motoyama S; Hashimoto M; Nomura K; Minamiya Y
Thorac Cancer; 2022 Mar; 13(5):708-715. PubMed ID: 35048499
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of
Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary staging in lung Adenocarcinoma: a Prospective Study.
Li Y; Lin X; Li Y; Lv J; Hou P; Liu S; Chen P; Wang M; Zhou C; Wang X
Mol Imaging Biol; 2022 Apr; 24(2):309-320. PubMed ID: 34816283
[TBL] [Abstract] [Full Text] [Related]
20.
Mittlmeier LM; Todica A; Gildehaus FJ; Unterrainer M; Beyer L; Brendel M; Albert NL; Ledderose ST; Vettermann FJ; Schott M; Rodler S; Marcon J; Ilhan H; Cyran CC; Stief CG; Staehler M; Bartenstein P
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1711-1720. PubMed ID: 34708249
[TBL] [Abstract] [Full Text] [Related]
[Next]
